Skip to content

Comparison of Frequency of Use of Optive and Systane

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00406510
Enrollment
Unknown
Registered
2006-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2007-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Brief summary

The purpose of this study is subjectively compare duration of action between Optive and Systane.

Interventions

DRUGOptive, Systane

Sponsors

Innovative Medical
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Males or females \> 18 years old * Mild to moderate dry eye symptoms * Score of at least 2 and no more than 4 on the SESOD at the initial screening visit * Likely to complete all study visits and able to provide informed consent

Exclusion criteria

* Current use of topical cyclosporine * Known contraindications to any study medication or ingredients * Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable) * Ocular surgery within the past 3 months, * Active ocular allergies

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026